Academy Project funding for two HYBER professors
The applications of HYBER professors Robin Ras and Mauri Kostiainen were funded in the Academy of Finland's September 2016 Project funding call.
Robin's project, ULTRAPHOTOSTABLE, is focused on developing ultraphotostable fluorescent markers. Poor photostability of fluorescent materials hinders the progress of the related technological and biological applications. The proposed project aims to open up possibilities to e.g. follow intracellular interactions with greatly enhanced spatial resolution and track single particle movements. The project is a consortium project with Prof. Juha Toivonen from Tampere University of Technology.
Mauri’s project, SYNVIRO, aims to develop new safe, synthetic, biohybrid materials to bind, encapsulate and remove heparin efficiently. Heparin is a polyelectrolyte widely used as a blood anti-coagulant. However, the effect of heparin needs to be rapidly neutralized after surgical operations or before blood sample analyses. In the SYNVIRO project, new virus-mimicking materials with encapsulating features are synthesized, thus allowing better understanding and control of polyelectrolyte encapsulation.
Read more news
Aalto Inventors turns one: A year of bridging research and real-world impact
Aalto Inventors marks its first anniversary, having engaged 190 researchers across six cohorts in fields including AI, quantum, and biomaterials. New cohorts are planned for the next academic year, stay tuned and join the waitlist.
An architectural project in Milan brought together children’s ideas and the visions of leading architects
911±¬ÁÏ꿉۪s Department of Architecture participated in the international One Earth – House of the Heart project, which was presented in April at Milan Design Week.
Companies disclose more on cybersecurity – but markets remain indifferent
U.S. companies are reporting on cybersecurity in greater detail, yet stock market reactions remain muted. A new study by the University of Vaasa and 911±¬ÁÏÍø shows that mandatory cybersecurity disclosure does not prompt reactions from investors or stock analysts. Instead, the main benefits appear to materialise within firms themselves.